T regulatory cells

BIOLOGICAL3 trials

Sponsors

University of Liege, Masonic Cancer Center, University of Minnesota, Stanford University

Conditions

Acute Graft-Versus-Host DiseaseAcute Respiratory Distress SyndromeChronic Graft-Versus-Host DiseaseCovid19Hematologic MalignanciesSteroid Refractory Graft-Versus-Host Disease

Phase 1

Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome

WithdrawnNCT04737161

Stanford UniversityAcute Respiratory Distress Syndrome, Covid19

Start: 2021-03-31End: 2022-09-30Updated: 2021-04-19

Phase 2

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

TerminatedNCT01903473

University of LiegeAcute Graft-Versus-Host Disease, Chronic Graft-Versus-Host Disease, Steroid Refractory Graft-Versus-Host Disease

Start: 2013-07-31End: 2022-09-12Updated: 2022-09-22

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

WithdrawnNCT02118311

Masonic Cancer Center, University of MinnesotaHematologic Malignancies

Start: 2016-06-30End: 2018-09-30Updated: 2017-12-02